Menu
Search
Sunday, March 15, 2026

Creating liberating content

Email us
Subscribe
Menu
Search

AstraZeneca to Acquire EsoBiotec...

By engineering immune cells directly within the patient’s body, EsoBiotec is eliminating the barriers of traditional cell therapies and unlocking new possibilities for oncology and immune-mediated diseases.

Signal12 gears up for...

BOSTON, March 18, 2025: Signal12, a clinical-stage ophthalmic pharmaceutical company has announced the...
Home2026March15

Daily Archives: Mar 15, 2026

Discover all articles written based on the date that they were written. An online archive that can be browsed at your leisure.

AstraZeneca to Acquire EsoBiotec for...

By engineering immune cells directly within the patient’s body, EsoBiotec is eliminating the barriers of traditional cell therapies and unlocking new possibilities for oncology and immune-mediated diseases.

Signal12 gears up for phase...

BOSTON, March 18, 2025: Signal12, a clinical-stage...
Uncategorized

Sample post title 0

Sample post no 0 excerpt.
Author name -
Uncategorized

Sample post title 1

Sample post no 1 excerpt.
Author name -
Uncategorized

Sample post title 2

Sample post no 2 excerpt.
Author name -
Uncategorized

Sample post title 3

Sample post no 3 excerpt.
Author name -
Uncategorized

Sample post title 4

Sample post no 4 excerpt.
Author name -
Uncategorized

Sample post title 5

Sample post no 5 excerpt.
Author name -
Uncategorized

Sample post title 6

Sample post no 6 excerpt.
Author name -
Uncategorized

Sample post title 7

Sample post no 7 excerpt.
Author name -
Uncategorized

Sample post title 8

Sample post no 8 excerpt.
Author name -
Uncategorized

Sample post title 9

Sample post no 9 excerpt.
Author name -

Explore more

Enjoy exclusive access to our content

Get an online subscription and you can unlock any article you come across, getting instant emails when our site updates, too.

Subscribe today ⟶

Amsonia Menu

Categories to explore

BahrainBiopharmaBiotechCorporateEventsFeaturesGlobal

Contribute as an author

Who we are